Jennifer Keiser
Clinical trials sponsored by Jennifer Keiser, explained in plain language.
-
New hope for kids with liver fluke: drug dose trial launched
Disease control Not yet recruitingThis study tests different doses of a new drug, arpraziquantel, in 125 children aged 6-7 who have a liver fluke infection called Opisthorchis viverrini. The goal is to find the dose that cures the most children with the fewest side effects. Children will provide stool samples bef…
Phase: PHASE2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New drug aims to outshine standard whipworm treatment in phase II trial
Disease control Not yet recruitingThis study compares a single dose of the experimental drug emodepside to the standard treatment albendazole for people aged 12 and older infected with Trichuris incognita (whipworm). About 100 participants will receive one dose of either drug and be checked 14-21 days later to se…
Phase: PHASE2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated May 26, 2026 12:01 UTC